First healthy volunteers enrolled in phase I study of GRAd-COV2 COVID-19 vaccine candidate Aug. 26, 2020
Targeting SARS-CoV-2 papain-like protease suppresses viral infection and promotes antiviral immunity Aug. 24, 2020